Erythropoietin enhances response to treatment in patients with advanced breast cancer

Anna-Maria Larsson; Göran Landberg; Sven Påhlman; Maria Albertsson

doi:10.1080/02841860410018179

Erythropoietin enhances response to treatment in patients with advanced breast cancer

Anna-Maria Larsson, Göran Landberg, Sven Påhlman, Maria Albertsson

Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial

Originalspråk	engelska
Sidor (från-till)	594-597
Tidskrift	Acta Oncologica
Volym	43
Nummer	6
DOI	https://doi.org/10.1080/02841860410018179
Status	Published - 2004

Bibliografisk information

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Pathology (Malmö) (013031000), Molecular Medicine (013031200), Oncology, MV (013035000)

Ämnesklassifikation (UKÄ)

Cancer och onkologi

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1080/02841860410018179

1 Doktorsavhandling (sammanläggning)

Translational Aspects of Erythropoietin Receptor and Hypoxia-Inducible Factors in Breast Cancer
Larsson, A.-M., 2012, Center for Molecular Pathology, Faculty of Medicine. 130 s.
Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

Fil

Citera det här

@article{823b5d780185450289dbd5983e83c13d,

title = "Erythropoietin enhances response to treatment in patients with advanced breast cancer",

author = "Anna-Maria Larsson and G{\"o}ran Landberg and Sven P{\aa}hlman and Maria Albertsson",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology (Malm{\"o}) (013031000), Molecular Medicine (013031200), Oncology, MV (013035000)",

year = "2004",

doi = "10.1080/02841860410018179",

language = "English",

volume = "43",

pages = "594--597",

journal = "Acta Oncologica",

issn = "1651-226X",

publisher = "Taylor & Francis",

number = "6",

}

TY - JOUR

T1 - Erythropoietin enhances response to treatment in patients with advanced breast cancer

AU - Larsson, Anna-Maria

AU - Landberg, Göran

AU - Påhlman, Sven

AU - Albertsson, Maria

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology (Malmö) (013031000), Molecular Medicine (013031200), Oncology, MV (013035000)

PY - 2004

Y1 - 2004

U2 - 10.1080/02841860410018179

DO - 10.1080/02841860410018179

M3 - Debate/Note/Editorial

C2 - 15370620

SN - 1651-226X

VL - 43

SP - 594

EP - 597

JO - Acta Oncologica

JF - Acta Oncologica

IS - 6

ER -

Erythropoietin enhances response to treatment in patients with advanced breast cancer

Bibliografisk information

Ämnesklassifikation (UKÄ)

FN:s Globala mål

Tillgång till dokument

Forskningsoutput

Translational Aspects of Erythropoietin Receptor and Hypoxia-Inducible Factors in Breast Cancer

Citera det här